Nutritional status and intake in patients with non-cystic fibrosis bronchiectasis (NCFB)-a cross sectional study

被引:2
|
作者
King, Linsey [1 ,3 ]
White, Helen [3 ]
Clifton, Ian [2 ]
Spoletini, Giulia [2 ]
Ispoglou, Theocharis [3 ]
Peckham, Daniel G. [1 ,3 ]
机构
[1] Univ Leeds, Clinical Sci Bldg,Beckett St, Leeds LS9 7TF, W Yorkshire, England
[2] Leeds Teaching Hosp Trusts, Beckett St, Leeds LS9 7TF, W Yorkshire, England
[3] Leeds Beckett Univ, Calverley St, Leeds LS1 3HE, W Yorkshire, England
关键词
Nutrition; Bronchiectasis; Body composition; OBSTRUCTIVE PULMONARY-DISEASE; HANDGRIP STRENGTH; VITAMIN-D; SEVERITY; MICROBIOME; PEOPLE; ADULTS;
D O I
10.1016/j.clnu.2021.07.032
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Bronchiectasis is a heterogeneous, chronic respiratory condition, in which the role of nutrition remains unclear and nutritional guidance is lacking. Few studies have explored the role of nutrition in disease management, and little is known about nutritional requirements during periods of stability or metabolic stress. The aim of this study was to characterise nutritional status and intakes in a cohort of patients and identify potential associations with body composition and functional capacity. Methods: A prospective observational cohort study was undertaken in an adult population (>17 years). Bronchiectasis was confirmed by high-resolution computerised tomography (HRCT). Anthropometric (weight, height, Body Mass Index (BMI), triceps skinfold thickness (TSF), mid upper-arm circumference (MUAC) and mid arm muscle circumference (MAMC)] lung function and nutritional intakes were measured. Results were analysed as a whole and by disease aetiology [primary ciliary dyskinesia (PCD), Idiopathic cause (IC), bronchiectasis in association with asthma and other] and associations tested. Results: In total, 128 participants (65.5% female) completed the study. Median handgrip strength (HGS) in the total sample was only 66.5% (IQR 60.5-89.8) of reference population norms and was low for those with PCD [58.0% (IQR 43.5-70.0))]. Univariate regression indicated that BMI was a statistically significant predictor of lung function in the whole population with HGS and weight identified as statistically significant predictors of lung function in PCD. The total population and each sub-group failed to meet estimated average requirements for energy but exceeded the Reference nutrient intake (RNI) for protein. Vitamin D was consistently <35% of the RNI. Conclusion: BMI lay within normal to overweight ranges within the whole population and sub-groups, but masked important functional, body composition and nutritional deficits. This was particularly so within a younger sub-group with PCD, who had impaired muscle function, when compared to other causal and associative diseases. (c) 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:5162 / 5168
页数:7
相关论文
共 50 条
  • [21] Nontuberculous Mycobacteria in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis
    Park, In Kwon
    Olivier, Kenneth N.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (02) : 217 - 224
  • [22] Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis
    Lee, J-K.
    Lee, J.
    Park, S. S.
    Heo, E. Y.
    Park, Y. S.
    Lee, C. H.
    Lee, S-M.
    Yoon, H. I.
    Yim, J-J.
    Yoo, C-G.
    Chung, H. S.
    Kim, Y. W.
    Han, S. K.
    Kim, D. K.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (03) : 363 - 370
  • [23] Using Cystic Fibrosis Therapies for Non-Cystic Fibrosis Bronchiectasis
    ElMaraachli, Wael
    Conrad, Douglas J.
    Wang, Angela C. C.
    CLINICS IN CHEST MEDICINE, 2016, 37 (01) : 139 - +
  • [24] Cost of Hospitalizations due to Exacerbation in Patients with Non-Cystic Fibrosis Bronchiectasis
    de la Rosa Carrillo, David
    Navarro Rolon, Annie
    Giron Moreno, Rosa Maria
    Montull Veiga, Beatriz
    Olveira Fuster, Casilda
    Padilla Galo, Alicia
    Prados Sanchez, Concepcion
    Quintana Gallego, Esther
    Sibila Vidal, Oriol
    Celorrio Jimenez, Nuria
    Ruiz Pena, Antonio
    Torres Marti, Antoni
    Aviles Ingles, Maria Jesus
    Blanco Aparicio, Marina
    Garcia-Clemente, Marta
    Golpe Gomez, Rafael
    Gomez Bonilla, Ainhoa
    Gomez Gonzalez, Cristina
    Leal Arranz, Maria Victoria
    Minguez Clemente, Patricia
    Lopez Muniz, Belen
    Maiz Carro, Luis
    Pando Sandoval, Ana
    Rodriguez Hermosa, Juan Luis
    Uranga Echeverria, Ane
    Nunez Ares, Ana
    Lopez Roldan, Lorena
    Abellan Martinez, Carmen
    Martinez Garcia, Abel Jesus
    Michel de la Rosa, Francisco Javier
    Godoy Mayoral, Raul
    Angel Martinez-Garcia, Miguel
    RESPIRATION, 2018, 96 (05) : 406 - 416
  • [25] Clinical impact of depression and anxiety in patients with non-cystic fibrosis bronchiectasis
    Bekir, Melahat
    Kocakaya, Derya
    Balcan, Baran
    Olgun Yildizeli, Sehnaz
    Eryuksel, Emel
    Ceyhan, Berrin
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2020, 68 (02): : 103 - 111
  • [26] Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Motta, Heryk
    Reuwsaat, Julia Catarina Vieira
    Lopes, Fernanda Cortez
    Viezzer, Graciele
    Volpato, Fabiana Caroline Zempulski
    Barth, Afonso Luis
    de Tarso Roth Dalcin, Paulo
    Staats, Charley Christian
    Vainstein, Marilene Henning
    Kmetzsch, Livia
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [27] Ethnicity, socioeconomic status and the severity and course of non-cystic fibrosis bronchiectasis
    de Boer, Sally
    Lewis, Christopher A.
    Fergusson, Wendy
    Ellyett, Kevin
    Wilsher, Margaret L.
    INTERNAL MEDICINE JOURNAL, 2018, 48 (07) : 845 - 850
  • [28] Exercise capacity in patients with cystic fibrosis vs. non-cystic fibrosis bronchiectasis
    Bar-Yoseph, Ronen
    Ilivitzki, Anat
    Cooper, Dan M.
    Gur, Michal
    Mainzer, Gur
    Hakim, Fahed
    Livnat, Galit
    Schnapp, Zeev
    Shalloufeh, George
    Zucker-Toledano, Merav
    Subar, Yael
    Bentur, Lea
    PLOS ONE, 2019, 14 (06):
  • [29] Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis
    Chang, Hsien-Cheng
    Omar, Ahmed
    Swift, Simon
    Vandal, Alain C.
    Liu, George
    Kyme, Pierre
    Wong, Conroy
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [30] Understanding patients' experience of living with non-cystic fibrosis bronchiectasis
    Spinou, Arietta
    Patel, Amit
    Garrod, Rachel
    Elston, Caroline
    Michael, Loebinger
    Robert, Wilson
    Birring, Surinder
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42